194 related articles for article (PubMed ID: 9274677)
1. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
2. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
Stuart-Harris RC; Lauchlan R; Day R
Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy: the interferon-alpha experience.
Kirkwood J
Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
[TBL] [Abstract][Full Text] [Related]
4. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
5. Interferon therapy of hematologic malignancies.
Foon KA
Cancer Treat Res; 1998; 94():1-21. PubMed ID: 9587679
[No Abstract] [Full Text] [Related]
6. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
[TBL] [Abstract][Full Text] [Related]
7. Interferon alfa-associated anterior ischemic optic neuropathy.
Fraunfelder FW; Fraunfelder FT
Ophthalmology; 2011 Feb; 118(2):408-11.e1-2. PubMed ID: 20630599
[TBL] [Abstract][Full Text] [Related]
8. The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.
Beelen DW; Elmaagacli AH; Schaefer UW
Blood; 1999 Mar; 93(5):1779-10. PubMed ID: 10084816
[No Abstract] [Full Text] [Related]
9. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
Molloy PJ; Azzouz M; Van Thiel DH
Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
[TBL] [Abstract][Full Text] [Related]
10. Biology and therapy of epidemic Kaposi's sarcoma.
Groopman JE
Cancer; 1987 Feb; 59(3 Suppl):633-7. PubMed ID: 10822462
[TBL] [Abstract][Full Text] [Related]
11. Criteria for use of interferon alfa-2a or interferon alfa-2b for selected indications in adults.
Am J Hosp Pharm; 1994 Apr; 51(8):1030-3. PubMed ID: 7518650
[No Abstract] [Full Text] [Related]
12. Interferons in oncology.
Woll PJ; Pettengell R
Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
[TBL] [Abstract][Full Text] [Related]
13. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
14. [Interferon-alpha in therapy of malignant hemoblastoses].
Schuler M; Aulitzky WE; Schneller F; Peschel C; Huber C
Internist (Berl); 1995 Dec; 36(12):1133-8. PubMed ID: 8567218
[No Abstract] [Full Text] [Related]
15. [Antineoplastic effects of interferons].
Shimoyama M
Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
[No Abstract] [Full Text] [Related]
16. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
17. AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?
Krown SE
Cytokine Growth Factor Rev; 2007; 18(5-6):395-402. PubMed ID: 17656146
[TBL] [Abstract][Full Text] [Related]
18. Leukemia and myelomatosis.
Catovsky D
Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
[No Abstract] [Full Text] [Related]
19. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
Baer MR; Ozer H; Foon KA
Br J Haematol; 1992 Jun; 81(2):167-9. PubMed ID: 1643013
[TBL] [Abstract][Full Text] [Related]
20. Why we should treat chronic viral hepatitis.
King PD
Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
[No Abstract] [Full Text] [Related]
[Next] [New Search]